Parkinson's disease (PD) is a common and complex neurodegenerative disorder with 5 stages in the Hoehn and Yahr scaling. Given the heterogeneity of PD, it is challenging to classify early stages 1 and 2 and detect brain function alterations. Functional magnetic resonance imaging (fMRI) is a promising tool in revealing functional connectivity (FC) differences and developing biomarkers in PD. Some machine learning approaches like support vector machine and logistic regression have been successfully applied in the early diagnosis of PD using fMRI data, which outperform classifiers based on manually selected morphological features. However, the early-stage characterization in FC changes has not been fully investigated. Given the complexity and ...
Resting state fMRI (rfMRI) is gaining in popularity, being easy to acquire and with promising clinic...
<div><p>Since anatomic MRI is presently not able to directly discern neuronal loss in Parkinson’s Di...
Parkinson’s Disease (PD) is the fastest growing neurodegenerative disease, currently affecting two t...
OBJECTIVES:Evaluation of a data-driven, model-based classification approach to discriminate idiopath...
There is growing interest in the potential of neuroimaging to help develop non-invasive biomarkers i...
The psychological field has recently been utilizing big data for both financial and research purpose...
Background In the absence of validated biomarkers, the early diagnosis of Parkinson’s disease (PD),...
Background. Pathological processes in Parkinson’s disease (PD) start long before the first symptoms ...
Parkinson's disease (PD) is the most common neurological disorder, after Alzheimer's disease, and is...
Background: The severity of motor symptoms in Parkinson's disease (PD) does not always correlate wit...
Parkinson’s disease (PD) is one of the most prevalent progressive, neurodegenerative disorders that ...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder characterized by a lar...
Structural MRI (sMRI) has been widely used to examine the cerebral changes that occur in Parkinson's...
Resting-state functional magnetic resonance imaging (RS-fMRI) studies have been extensively applied ...
Resting state fMRI (rfMRI) is gaining in popularity, being easy to acquire and with promising clinic...
<div><p>Since anatomic MRI is presently not able to directly discern neuronal loss in Parkinson’s Di...
Parkinson’s Disease (PD) is the fastest growing neurodegenerative disease, currently affecting two t...
OBJECTIVES:Evaluation of a data-driven, model-based classification approach to discriminate idiopath...
There is growing interest in the potential of neuroimaging to help develop non-invasive biomarkers i...
The psychological field has recently been utilizing big data for both financial and research purpose...
Background In the absence of validated biomarkers, the early diagnosis of Parkinson’s disease (PD),...
Background. Pathological processes in Parkinson’s disease (PD) start long before the first symptoms ...
Parkinson's disease (PD) is the most common neurological disorder, after Alzheimer's disease, and is...
Background: The severity of motor symptoms in Parkinson's disease (PD) does not always correlate wit...
Parkinson’s disease (PD) is one of the most prevalent progressive, neurodegenerative disorders that ...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder characterized by a lar...
Structural MRI (sMRI) has been widely used to examine the cerebral changes that occur in Parkinson's...
Resting-state functional magnetic resonance imaging (RS-fMRI) studies have been extensively applied ...
Resting state fMRI (rfMRI) is gaining in popularity, being easy to acquire and with promising clinic...
<div><p>Since anatomic MRI is presently not able to directly discern neuronal loss in Parkinson’s Di...
Parkinson’s Disease (PD) is the fastest growing neurodegenerative disease, currently affecting two t...